Do Carbs Cause Cancer? A Look at the Scientific Evidence

Carbohydrates as a broad category do not cause cancer. Eating a potato or a bowl of rice does not flip a switch that triggers tumor growth. But the relationship between carbohydrates and cancer risk is far from simple, because “carbs” is an enormous umbrella covering everything from lentils and oats to soda and white bread. The scientific evidence points consistently in one direction: what matters is not how many carbohydrates you eat, but what kind. Refined sugars and ultra-processed carbohydrate foods are linked to modestly higher cancer risk in large studies, while whole grains and fiber-rich carbohydrates appear to be protective.

Why Carbohydrates Get Blamed

The idea that carbs feed cancer has roots in a real biological observation. Cancer cells consume glucose at a much higher rate than normal cells, even when oxygen is plentiful. This phenomenon, first described in the 1920s, is sometimes called the Warburg effect. Researchers have long debated whether this unusual sugar-hungry metabolism is a consequence of the genetic changes that make a cell cancerous or whether it plays a role in driving cancer itself. That question still doesn’t have a settled answer.¹ But the leap from “cancer cells use a lot of glucose” to “eating carbs feeds your cancer” is a misunderstanding. Your body tightly regulates blood sugar. Whether you eat a bagel or skip breakfast, your liver releases glucose into your bloodstream to keep your brain and organs running. You cannot starve cancer cells of glucose by cutting carbs from your diet without also starving the rest of your body.

A more grounded concern involves insulin and insulin-like growth factor (IGF). When you eat carbohydrates, especially quickly digested ones, your blood sugar rises and your pancreas releases insulin. Chronically elevated insulin and IGF levels have been linked in both lab and population studies to the development and progression of several cancer types. Insulin promotes cell growth and suppresses a form of programmed cell death that normally keeps abnormal cells in check.² This does not mean insulin is a carcinogen. It means a dietary pattern that keeps insulin chronically elevated, through constant snacking on sugary or highly refined foods, for instance, may create a hormonal environment that nudges cancer risk upward over time.

Carbohydrate Quality Matters More Than Quantity

One of the most telling findings in recent research is that the total amount of carbohydrate in your diet does not reliably predict cancer risk, but the quality of those carbohydrates does. A large prospective U.S. study scored people’s diets using a carbohydrate quality index that accounted for factors like fiber content, whole-grain-to-total-grain ratio, and how much of the carbohydrate came from whole foods versus refined sources. People in the top quarter of carbohydrate quality had about a 20% lower risk of developing colorectal cancer and roughly 39% lower colorectal cancer mortality compared to those in the bottom quarter.³ Meanwhile, simply eating fewer carbohydrates overall showed no meaningful association with colorectal cancer risk in the same study.

This pattern holds across other cancer types. Multiple epidemiological studies have found that people who eat more whole grains have lower rates of breast cancer.⁴ For colorectal cancer specifically, a large cohort study found that people eating the most whole grains had a 16% lower risk of colorectal cancer, with an even stronger protective effect for rectal cancer, where the risk reduction reached about 24%.⁵

One reason whole grains may protect against cancer involves what happens in your gut. Bacteria in the colon ferment dietary fiber into short-chain fatty acids, including butyrate. Butyrate has anti-cancer effects on colon cells in lab settings. Researchers have found that people with colon cancer or precancerous polyps produce a lower proportion of butyrate from fiber fermentation compared to healthy people.⁶ Whether this reduced butyrate production is a cause or a consequence of the cancer process remains debated, but the finding reinforces that fiber-rich carbohydrates interact with the gut in ways that may keep the colon healthier.

Sugary Drinks and Refined Sugars

If carbohydrate quality is the key variable, sugar-sweetened beverages sit at the wrong end of the spectrum. A large French prospective cohort found that sugary drink consumption was associated with increased overall cancer risk, with the connection remaining even after researchers accounted for body weight, weight changes during follow-up, and overall diet quality. The researchers noted that the link persisted whether they adjusted for BMI at baseline, treated it as a time-dependent variable, or stratified by weight-change categories. This suggests that excess body fat is not the only mechanism connecting sugary drinks to cancer.⁷

Other pathways may be at play. Sugary drinks have a high glycemic load, meaning they spike blood sugar rapidly. That spike triggers insulin surges and has been associated with chronic low-grade inflammation, both of which are implicated in tumor development. The same cohort study found that sugary drink consumption was independently linked to increased visceral fat, the deep abdominal fat that wraps around organs. Visceral fat is metabolically active and secretes hormones and signaling molecules that can promote tumor growth in ways that go beyond simple weight gain.

More recent work supports the concern. A study analyzing data from a large UK cohort found that women who drank one or more portions of sugar-sweetened beverages per week had about 58% higher breast cancer risk compared to those who drank less than one portion per week. The association was partly mediated through BMI and uric acid levels.⁸ For breast cancer specifically, a meta-analysis found that diets with the highest glycemic index were associated with about 5% higher risk compared to the lowest, a modest but statistically meaningful increase across a large number of women.⁹

Ultra-Processed Foods and Cooking-Related Compounds

Many of the carbohydrate-rich foods people eat most are not just refined but ultra-processed: packaged snacks, breakfast cereals with long ingredient lists, mass-produced breads and pastries. A French prospective cohort found that every 10-percentage-point increase in the share of ultra-processed foods in a person’s diet was associated with a 12% higher overall cancer risk and an 11% increase in breast cancer risk, even after adjusting for fat, sodium, and carbohydrate intake.¹⁰ A separate analysis of three large U.S. cohorts found that men in the top fifth of ultra-processed food consumption had a 29% higher risk of colorectal cancer, though interestingly, no such association was seen in women.¹¹

Beyond the nutritional profile of these foods, cooking and processing can create chemical compounds that raise their own concerns. Acrylamide forms when starchy foods like potatoes, bread, and biscuits are heated to high temperatures, as in frying, baking, or toasting. The International Agency for Research on Cancer classifies acrylamide as a “probable human carcinogen” based on animal studies, but the evidence from human populations is inconsistent. A systematic review of 41 studies found that while some reported positive associations between dietary acrylamide and cancers of the reproductive, urinary, or gastrointestinal systems, many others found no relationship.¹² Part of the problem is that measuring how much acrylamide a person actually consumes through diet is extremely difficult, and methods for estimating exposure vary widely across studies. The risk, if present, appears to be small at the levels people typically encounter through food.

The Diabetes and Obesity Connection

One of the clearest links between carbohydrate metabolism and cancer runs through metabolic disease. People with type 2 diabetes face up to double the risk of cancers of the colon, breast, endometrium, kidney, liver, and pancreas compared to people without diabetes.¹³ The same research suggests that chronically elevated blood glucose and insulin, even within the non-diabetic range, may independently raise cancer risk. In other words, you do not need a diabetes diagnosis for poor blood sugar regulation to matter.¹⁴

This helps explain why eating patterns that chronically spike blood sugar, dominated by refined carbohydrates, sugary drinks, and ultra-processed snacks, are associated with higher cancer rates even in studies that try to control for body weight. Obesity itself is a well-established cancer risk factor, linked to cancers of the esophagus, stomach, pancreas, gallbladder, liver, colon, breast (after menopause), ovary, endometrium, prostate, and kidney. But the metabolic dysfunction that comes with a diet heavy in refined carbs, including insulin resistance, chronic inflammation, and unfavorable shifts in fat distribution, may raise risk through pathways that overlap with but are not identical to simple excess weight.

Do Artificial Sweeteners Offer a Safer Alternative?

If sugar is the concern, swapping to diet soda or packets of artificial sweetener might seem like a logical fix. The evidence here is genuinely mixed. A large umbrella meta-analysis pooling results across study designs found no significant association between artificial sweetener intake and cancer risk overall.¹⁵ That review explicitly noted that findings for sweeteners grouped together should not be applied to individual compounds.

And individual compounds do show signals worth watching. In the NutriNet-Santé cohort, higher consumers of artificial sweeteners overall had about 13% higher risk of cancer compared to non-consumers, with aspartame in particular associated with a 15% increased risk and a 22% increase specifically for breast cancer.¹⁶ This is a single cohort study, not a clinical trial, so it cannot prove causation. People who use a lot of artificial sweeteners may differ from non-users in ways researchers cannot fully account for. But the finding underscores that artificial sweeteners are not automatically risk-free and that more research into individual sweetener compounds is needed.

Does Going Keto Protect Against Cancer?

The ketogenic diet, which slashes carbohydrate intake to a bare minimum and replaces it with fat, has attracted enormous interest as a potential anti-cancer strategy. The reasoning draws on the Warburg effect: if cancer cells depend on glucose, depriving them of it by switching the body’s fuel to ketone bodies might slow tumor growth. Some researchers have explored whether ketogenic diets could work alongside standard cancer treatments like chemotherapy and radiation.¹⁷

The reality, however, is more complicated than the theory. Most evidence for keto as a cancer treatment comes from animal studies and small clinical observations, not large-scale human trials. And when researchers looked at the relationship between ketogenic-style eating patterns and cancer rates in a large U.S. population survey spanning nearly two decades, they found the opposite of what keto proponents might expect: people whose diets most closely resembled a ketogenic pattern had about 29% higher cancer risk overall compared to those with the lowest ketogenic ratio.¹⁸ That study was cross-sectional, meaning it captured a snapshot rather than tracking people over time, so it cannot establish that the keto diet caused the higher rates. People eating very high-fat diets may also eat more red meat, fewer vegetables, and less fiber, all of which have their own cancer associations. Still, the finding should give pause to anyone assuming that eliminating carbs automatically reduces cancer risk.

Fructose, the Liver, and a Less Obvious Pathway

Not all sugars act the same way in the body. Fructose, which makes up about half of table sugar and a larger share of high-fructose corn syrup, takes a different metabolic route than glucose. Most fructose travels directly to the liver via the portal vein, arriving there at much higher concentrations than in other tissues. Unlike glucose, fructose does not need insulin to be metabolized, and it directly ramps up the liver’s fat-producing machinery. This process increases levels of all the enzymes involved in turning sugar into fat, even more potently than a high-fat diet does. Fructose also stimulates a key genetic switch for fat production that stays active even in the setting of insulin resistance. The end result is that high fructose intake can drive fat accumulation in the liver and around the organs, independent of total calorie intake. Since fatty liver disease, visceral fat, and chronic inflammation are all linked to elevated cancer risk, heavy fructose consumption may be an underappreciated piece of the carbohydrate-cancer puzzle.

When You Eat May Also Matter

A newer area of research suggests that the timing of carbohydrate intake, not just the type, may influence cancer risk. Your body handles glucose differently at different times of day. Insulin sensitivity is typically highest in the morning and declines as the day goes on, meaning the same meal eaten at 8 a.m. produces a smaller insulin spike than the same meal eaten at 10 p.m. Disrupting this natural rhythm through shift work or habitual late-night eating can impair hormonal balance and promote fat storage.¹⁹

In the NutriNet-Santé cohort, people whose last meal of the day fell after 9:30 p.m. had a 48% higher risk of breast cancer and more than double the risk of prostate cancer compared to earlier eaters, after adjusting for sleep duration and other factors. The number of meals per day, overall fasting duration overnight, and what time people ate their first meal did not matter. Only the late timing of the final meal showed a clear signal.²⁰ This is still emerging evidence, and one cohort study cannot establish causation. But it adds another layer to the picture: a bowl of refined pasta at noon and the same bowl at midnight may carry different metabolic consequences.

Why Diet-Cancer Research Feels So Confusing

If you have followed media coverage of diet and cancer, you have probably seen contradictory headlines: one week coffee prevents cancer, the next week it causes it. This confusion is not just media hype. The underlying research faces genuine challenges. People do not eat single nutrients in isolation; they eat complex meals embedded in complex lives. Separating the effect of carbohydrates from the effects of the fat, protein, fiber, additives, cooking methods, and overall calorie count that accompany them is enormously difficult. Dietary patterns also correlate with exercise habits, sleep, smoking, socioeconomic status, and access to healthcare, all of which independently affect cancer risk.

Researchers have acknowledged that the reductionist approach of studying single nutrients in isolation, while useful in a lab, can produce misleading results when applied to something as tangled as human diets. The perception that diet-cancer evidence is inconsistent is widespread among both the public and health professionals, and it is partly justified: the tools for measuring what people eat over decades are imprecise, and the effect sizes for individual dietary components on cancer risk are usually small, in the range of 5-30% relative risk changes rather than the dramatic differences seen with something like smoking. That does not mean the effects are unimportant at a population level, but it does mean individual studies frequently disagree, and readers should be skeptical of any single headline that makes carbs sound like poison or a miracle shield.

The Gut Microbiome as a Middleman

Increasingly, researchers are paying attention to the trillions of microbes in the gut as a mediator between what you eat and whether it influences cancer. The types of carbohydrates you consume directly shape which bacterial populations thrive in your colon. Diets rich in fiber feed bacteria that produce butyrate and other short-chain fatty acids with anti-inflammatory and potentially anti-cancer properties. Diets dominated by simple sugars and processed starches shift the microbial balance in ways that can increase gut inflammation and compromise the gut lining. Some research suggests that dietary changes to the microbiome can affect not just cancers in the digestive tract but also the effectiveness of cancer therapies, including immunotherapy and chemotherapy, through downstream effects on the immune system. This is an active research area with more questions than answers, but it reinforces the emerging consensus that carbohydrate quality shapes the biological environment in your gut in ways that probably matter for long-term cancer risk.

How Hunter-Gatherer Diets Complicate the “Carbs Are Bad” Narrative

One popular argument for cutting carbs is that our ancestors did not eat them in large quantities, so our bodies are not “designed” for them. The evidence does not support this cleanly. A review of dietary patterns among modern hunter-gatherer and small-scale subsistence societies found that their diets tend to be less energy-dense and richer in fiber and micronutrients than typical modern diets, but are not uniformly low in carbohydrates.²¹ Many of these groups consume substantial amounts of tubers, fruit, and wild grains. What they rarely consume is refined sugar, white flour, or ultra-processed snack food. Their remarkably low rates of metabolic disease and cancer track much better with carbohydrate quality and overall dietary pattern than with macronutrient ratios alone. The lesson from these populations is not “avoid carbs” but rather “avoid the kinds of carbs that did not exist until industrial food processing invented them.”